Status:

UNKNOWN

Identifying Novel Biomarkers in Early Rheumatology Patients

Lead Sponsor:

Arthritis Northwest PLLC

Collaborating Sponsors:

Inova Diagnostics Inc

Bristol-Myers Squibb

Conditions:

Rheumatologic Disorder

Eligibility:

All Genders

18-100 years

Brief Summary

Patients new to a rheumatology practice will be asked if they want to consent to their blood sample, medical records, and hand/foot x-rays (with sharp scores) for the analysis and correlation with the...

Detailed Description

At the end of their first visit new rheumatology patients will be asked for their interest in joining the Inova biomarker study. If yes, the patient will be consented, blood will be drawn for the Inov...

Eligibility Criteria

Inclusion

  • Newly referred Arthritis Northwest PLLC
  • Age 18 or older

Exclusion

  • None.

Key Trial Info

Start Date :

March 15 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 15 2020

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT03843658

Start Date

March 15 2019

End Date

September 15 2020

Last Update

February 18 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Identifying Novel Biomarkers in Early Rheumatology Patients | DecenTrialz